China SXT Pharmaceuticals (SXTC) Leases (2023 - 2025)
Historic Leases for China SXT Pharmaceuticals (SXTC) over the last 3 years, with Q1 2025 value amounting to $176648.0.
- China SXT Pharmaceuticals' Leases fell 2510.09% to $176648.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $176648.0, marking a year-over-year decrease of 2510.09%. This contributed to the annual value of $176648.0 for FY2025, which is 2510.09% down from last year.
- According to the latest figures from Q1 2025, China SXT Pharmaceuticals' Leases is $176648.0, which was down 2510.09% from $235848.0 recorded in Q1 2024.
- Over the past 5 years, China SXT Pharmaceuticals' Leases peaked at $306050.0 during Q1 2023, and registered a low of $176648.0 during Q1 2025.
- In the last 3 years, China SXT Pharmaceuticals' Leases had a median value of $235848.0 in 2024 and averaged $239515.3.
- In the last 5 years, China SXT Pharmaceuticals' Leases plummeted by 2293.81% in 2024 and then tumbled by 2510.09% in 2025.
- Over the past 3 years, China SXT Pharmaceuticals' Leases (Quarter) stood at $306050.0 in 2023, then decreased by 22.94% to $235848.0 in 2024, then fell by 25.1% to $176648.0 in 2025.
- Its last three reported values are $176648.0 in Q1 2025, $235848.0 for Q1 2024, and $306050.0 during Q1 2023.